Cargando…
Effects of RANKL-Targeted Therapy in Immunity and Cancer
The role of the receptor activator of nuclear factor-κB ligand (RANKL)/RANK system is well characterized within bone, where RANKL/RANK signaling mediates osteoclastogenesis and bone resorption. However, this system has also been shown to influence biologic processes beyond the skeletal system, inclu...
Autores principales: | Cheng, Michael L., Fong, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882875/ https://www.ncbi.nlm.nih.gov/pubmed/24432249 http://dx.doi.org/10.3389/fonc.2013.00329 |
Ejemplares similares
-
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020) -
Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
por: Brouns, Anita J.W.M., et al.
Publicado: (2023) -
Targeting immune-onco-metabolism for precision cancer therapy
por: Pajai, Sakshi, et al.
Publicado: (2023) -
Targeting RANKL in metastasis
por: Dougall, William C, et al.
Publicado: (2014) -
Immune cells and immune cell-targeted therapy in chronic pancreatitis
por: Zhang, Yu, et al.
Publicado: (2023)